BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 193016)

  • 1. Immune surveillance--a powerful mechanism with a limited range.
    Klein G
    Natl Cancer Inst Monogr; 1976 Nov; 44():109-13. PubMed ID: 193016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of escape from immune surveillance.
    Klein G
    Natl Cancer Inst Monogr; 1976 Nov; 44():135-6. PubMed ID: 193018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous-cell carcinoma, Kaposi's sarcoma and Burkitt's lymphoma are consequences of impaired immune surveillance of ubiquitous viruses in acquired immune deficiency syndrome, allograft recipients and tropical African patients.
    Purtilo DT; Manolov G; Manolova Y; Harada S; Lipscomb H
    IARC Sci Publ; 1984; (63):749-70. PubMed ID: 6100288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
    Henle W; Henle G
    Ann Clin Lab Sci; 1974; 4(2):109-14. PubMed ID: 4362218
    [No Abstract]   [Full Text] [Related]  

  • 5. Viral aetiopathogenesis of tumors.
    Klein E
    Boll Ist Sieroter Milan; 1971; 50(3):140-51. PubMed ID: 4111986
    [No Abstract]   [Full Text] [Related]  

  • 6. Virus-specified proteins and their breakdown products. In: strategy of the viral genome.
    Ciba Found Symp; 1971; ():295-315. PubMed ID: 4337205
    [No Abstract]   [Full Text] [Related]  

  • 7. Rejectability of virus-induced tumors and nonrejectability of spontaneous tumors: a lesson in contrasts.
    Klein G; Klein E
    Transplant Proc; 1977 Mar; 9(1):1095-104. PubMed ID: 194366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
    Pearson G; Dewey F; Klein G; Henle G; Henle W
    J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for an oncogenic potential of the Epstein-Barr virus.
    Henle W; Henle G
    Cancer Res; 1973 Jun; 33(6):1419-23. PubMed ID: 4352376
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus infections.
    Middleton PJ
    Can Med Assoc J; 1974 Jan; 110(1):9-10. PubMed ID: 4358535
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution.
    Klein G; Klein E
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2121-5. PubMed ID: 194247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of tumor antigens and tumor-specific immune mechanisms in experimental systems.
    Law LW
    Transplant Proc; 1970 Mar; 2(1):117-32. PubMed ID: 4330038
    [No Abstract]   [Full Text] [Related]  

  • 13. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus and human malignancies.
    Henle W; Henle G
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1368-74. PubMed ID: 4370910
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunology and malignant disease.
    Klein E; Cochran AJ
    Haematologia (Budap); 1971; 5(3):179-203. PubMed ID: 4108507
    [No Abstract]   [Full Text] [Related]  

  • 16. MHC class I restricted T cells and immune surveillance against transplanted ultraviolet light-induced tumors.
    Ward PL; Schreiber H
    Semin Cancer Biol; 1991 Oct; 2(5):321-8. PubMed ID: 1837738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective immune surveillance in viral carcinogenesis.
    Purtilo DT
    Lab Invest; 1984 Oct; 51(4):373-85. PubMed ID: 6090808
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tumour antigens inducing immune reactions].
    Burtin P
    Ann Immunol (Paris); 1977; 128(1-2):507-16. PubMed ID: 192132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary. EB virus, infectious mononucleosis, and cancer: the closing of the web.
    Evans AS
    Yale J Biol Med; 1974; 47(2):113-22. PubMed ID: 4372814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.